Longevity of human islet α- and β-cells

Diabetes, Obesity and Metabolism

Volumn 13, Issue SUPPL. 1, 2011, Pages 39-46

  Cnop, M ^a,b   Igoillo Esteve, M ^a   Hughes, S J ^c   Walker, J N ^c,d   Cnop, I ^e   Clark, A ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Ageing; Diabetes; Islets; Lifespan; Longevity; Neogenesis; Proliferation; Replication; cells; cells

Indexed keywords

LIPOFUSCIN;

BODY MASS; CELL AGING; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; GENETIC PREDISPOSITION; HUMAN; LONGEVITY; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PLASTICITY; REVIEW;

EID: 79961205550     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01443.x     Document Type: Review

References (60)

1. Basu R, Breda E, Oberg AL et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 2003; 52: 1738-1748.
2. Bonawitz ND, Shadel GS. Rethinking the mitochondrial theory of aging: the role of mitochondrial gene expression in lifespan determination. Cell Cycle 2007; 6: 1574-1578.
3. Short KR, Bigelow ML, Kahl J et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A 2005; 102: 5618-5623.
4. Kujoth GC, Hiona A, Pugh TD et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005; 309: 481-484.
5. Maedler K, Schumann DM, Schulthess F et al. Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. Diabetes 2006; 55: 2455-2462.
6. Muller WA, Faloona GR, Aguilar-Parada E, Unger RH. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 1970; 283: 109-115.
7. Dunning BE, Gerich JE. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 2007; 28: 253-283.
8. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A 2010; 107: 16009-16012.
9. Braun M, Rorsman P. The glucagon-producing alpha cell: an electrophysiologically exceptional cell. Diabetologia 2010; 53: 1827-1830.
10. Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications Diabetologia 2004; 47: 581-589.
11. Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC, Sharma A. Beta-cell growth and regeneration: replication is only part of the story. Diabetes 2010; 59: 2340-2348.
12. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-46.
13. Xu X, D'Hoker J, Stange G et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008; 132: 197-207.
14. Scharfmann R. Expanding human beta cells. Diabetologia 2008; 51: 692-693.
15. Reers C, Erbel S, Esposito I et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol 2009; 160: 185-191.
16. Kohler CU, Olewinski M, Tannapfel A, Schmidt WE, Fritsch H, Meier JJ. Cell cycle control of beta-cell replication in the prenatal and postnatal human pancreas. Am J Physiol Endocrinol Metab 2011; 300: E221-230.
17. Cnop M, Hughes SJ, Igoillo-Esteve M et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 2010; 53: 321-330.
18. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
19. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 2006; 29: 717-718.
20. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10(Suppl. 4): 32-42.
21. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985; 4: 110-125.
22. Clark A, Wells CA, Buley ID et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988; 9: 151-159.
23. Henquin JC, Rahier J. Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia 2011; 54: 1720-1725.
24. Bonner-Weir S. beta-cell turnover: its assessment and implications. Diabetes 2001; 50(Suppl. 1): S20-24.
25. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 1995; 44: 249-256.
26. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000; 49: 1325-1333.
27. Hanley NA, Hanley KP, Miettinen PJ, Otonkoski T. Weighing up beta-cell mass in mice and humans: self-renewal, progenitors or stem cells? Mol Cell Endocrinol 2008; 288: 79-85.
28. Milner RD, Wirdnam PK, Tsanakas J. Quantitative morphology of B, A, D, and PP cells in infants of diabetic mothers. Diabetes 1981; 30: 271-274.
29. Butler AE, Cao-Minh L, Galasso R et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010; 53: 2167-2176.
30. Van Assche FA, Aerts L, De Prins F. A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 1978; 85: 818-820.
31. Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 1992; 130: 1459-1466.
32. Butler PC, Meier JJ, Butler AE, Bhushan A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 2007; 3: 758-768.
33. Meier JJ, Butler AE, Saisho Y et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008; 57: 1584-1594.
34. Guiot Y, Henquin JC, Rahier J. Effects of glibenclamide on pancreatic beta-cell proliferation in vivo. Eur J Pharmacol 1994; 261: 157-161.
35. Rankin MM, Kushner JA. Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes 2009; 58: 1365-1372.
36. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA. Very slow turnover of beta-cells in aged adult mice. Diabetes 2005; 54: 2557-2567.
37. Tschen SI, Dhawan S, Gurlo T, Bhushan A. Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 2009; 58: 1312-1320.
38. Manesso E, Toffolo GM, Butler AE, Butler PC, Cobelli C. Shortened beta cell lifespan leads to beta cell deficit in a rodent model of type 2 diabetes. Am J Physiol Endocrinol Metab 2011; 300: E993-998.
39. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866-868.
40. Takubo K, Nakamura K, Izumiyama N et al. Telomere shortening with aging in human liver. J Gerontol A Biol Sci Med Sci 2000; 55: B533-536.
41. Spalding KL, Bhardwaj RD, Buchholz BA, Druid H, Frisen J. Retrospective birth dating of cells in humans. Cell 2005; 122: 133-143.
42. Spalding KL, Arner E, Westermark PO et al. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783-787.
43. Bergmann O, Bhardwaj RD, Bernard S et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.
44. Perl S, Kushner JA, Buchholz BA et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 2010; 95: E234-239.
45. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol 2000; 24: 297-302.
46. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes. Diabetologia 2010; 53: 2020-2028.
47. Benavides SH, Monserrat AJ, Farina S, Porta EA. Sequential histochemical studies of neuronal lipofuscin in human cerebral cortex from the first to the ninth decade of life. Arch Gerontol Geriatr 2002; 34: 219-231.
48. Schmucker DL, Sachs H. Quantifying dense bodies and lipofuscin during aging: a morphologist's perspective. Arch Gerontol Geriatr 2002; 34: 249-261.
49. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann N Y Acad Sci 2004; 1019: 70-77.
50. Sulzer D, Mosharov E, Talloczy Z, Zucca FA, Simon JD, Zecca L. Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease. J Neurochem 2008; 106: 24-36.
51. Jung HS, Lee MS. Role of autophagy in diabetes and mitochondria. Ann N Y Acad Sci 2010; 1201: 79-83.
52. Meda P. Lysosomes in normal pancreatic beta cells. Diabetologia 1978; 14: 305-310.
53. Borg LA, Schnell AH. Lysosomes and pancreatic islet function: intracellular insulin degradation and lysosomal transformations. Diabetes Res 1986; 3: 277-285.
54. Mann DM, Yates PO, Stamp JE. The relationship between lipofuscin pigment and ageing in the human nervous system. J Neurol Sci 1978; 37: 83-93.
55. Cnop M, Grupping A, Hoorens A, Bouwens L, Pipeleers-Marichal M, Pipeleers D. Endocytosis of low-density lipoprotein by human pancreatic beta cells and uptake in lipid-storing vesicles, which increase with age. Am J Pathol 2000; 156: 237-244.
56. Manesso E, Toffolo GM, Saisho Y et al. Dynamics of beta-cell turnover: evidence for beta-cell turnover and regeneration from sources of beta-cells other than beta-cell replication in the HIP rat. Am J Physiol Endocrinol Metab 2009; 297: E323-330.
57. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
58. Kahn SE, Beard JC, Schwartz MW et al. Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 1989; 38: 562-568.
59. Ihm SH, Matsumoto I, Sawada T et al. Effect of donor age on function of isolated human islets. Diabetes 2006; 55: 1361-1368.
60. Terman A, Brunk UT. Oxidative stress, accumulation of biological 'garbage', and aging. Antioxid Redox Signal 2006; 8: 197-204.